Navigation Links
FierceBiotech Names VentiRx Pharmaceuticals as One of the 'Fierce 15' Biotech Companies of 2010
Date:9/15/2010

SAN DIEGO, Sept. 15 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has been named to the annual FierceBiotech "Fierce 15" list, designating it as one of the top and most promising biotech companies in the industry. Every year, FierceBiotech evaluates hundreds of private companies, which is based on a variety of factors such as the strength of its technology, partnerships and a competitive market position.  

"VentiRx started the year with a venture capital bang, adding $25 million to its bank account and bringing its total to more than $50 million," says John Carroll, editor of FierceBiotech. "It's using its money to advance small molecule drugs that spur Toll-like receptors - specifically TLR8 -- to rev up an immune response to fight off disease. And it plans to make the money last. When the developer pulled the wraps off its venture round, co-founder Michael Kamdar said that the company was well set to make it through to the next big funding event -- whether that turns out to be a partnership, a buyout or an IPO."

"We are honored to be recognized as one of the 'Fierce 15' by FierceBiotech," said Michael Kamdar, Co-Founder and Chief Business Officer at VentiRx. "We have made significant clinical progress in advancing our novel TLR8 agonists for the treatment of allergy and oncology, and look forward to further advancing our leadership position in TLR8 therapeutics."

"We believe that TLR8 is an exciting target relevant to many important human diseases," said Robert Hershberg, M.D., Ph.D., Co-Founder and Chief Medical Officer at VentiRx. "We are encouraged by the data we've seen to date with our VTX-1463 candidate for allergic rhinitis and VTX-2337 for oncology, and look forward to presenting additional data as it becomes available this year."

The Fierce 15 celebrates the spirit of being "Fierce" – championing innovation and creativity, even in the face of intense competition. The complete list of "Fierce 15" companies can be found at www.fiercebiotech.com.

About FierceBiotech

FierceBiotech is the biotech industry's daily monitor - a free email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval and regulation, biotech company deals and more. More than 75,000 top biotech professionals rely on FierceBiotech for an insider briefing on the day's top stories. Sign up is free at http://www.fiercebiotech.com.

About VentiRx Pharmaceuticals

VentiRx Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory and inflammatory diseases. The Company's initial focus is on developing small molecule TLR-based product candidates for oncology and allergy. VentiRx is a privately held organization headquartered in San Diego with operations in Seattle. For additional information, please visit www.ventirx.com.


'/>"/>
SOURCE VentiRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FierceBiotech Names Obesity Company Gelesis to Fierce 15 List of Top Emerging Biotech Companies
2. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
3. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
4. Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development
5. AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer
6. INC. 5000 Names ClinixMIS for Third Time
7. SL Industries Names Louis J. Belardi Chief Financial Officer
8. BayCare Health System Names Tim Thompson Chief Information Officer
9. Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
10. K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
11. Ikaria® Names New Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):